| Noor Yazdanie, MD | |
|
26077 Nelson Way Ste 1201, Katy, TX 77494-6698 | |
| (832) 437-6531 | |
| Not Available |
| Full Name | Noor Yazdanie |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 26077 Nelson Way Ste 1201, Katy, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710378310 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | Q9095 (Texas) | Primary |
| 207R00000X | Internal Medicine | Q9095 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Community Hospital | Columbus, TX | Hospital |
| Memorial Hermann Katy Hospital | Katy, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Katy Diabetes And Endocrinology Pllc | 8022473776 | 2 |
News Archive
Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
NovaBay(R) Pharmaceuticals, Inc., a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, will deliver two poster presentations at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Substance abuse treatments that target main issues such as serious drug and alcohol addiction are not frequently being used to also wean adolescents from tobacco, a University of Georgia study finds.
› Verified 9 days ago
| Entity Name | Privia Medical Group Gulf Coast Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578969465 PECOS PAC ID: 4688999022 Enrollment ID: O20150206000763 |
News Archive
Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
NovaBay(R) Pharmaceuticals, Inc., a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, will deliver two poster presentations at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Substance abuse treatments that target main issues such as serious drug and alcohol addiction are not frequently being used to also wean adolescents from tobacco, a University of Georgia study finds.
› Verified 9 days ago
| Entity Name | Katy Diabetes And Endocrinology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639881048 PECOS PAC ID: 8022473776 Enrollment ID: O20230502001320 |
News Archive
Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
NovaBay(R) Pharmaceuticals, Inc., a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, will deliver two poster presentations at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Substance abuse treatments that target main issues such as serious drug and alcohol addiction are not frequently being used to also wean adolescents from tobacco, a University of Georgia study finds.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Noor Yazdanie, MD 26077 Nelson Way Ste 1201, Katy, TX 77494-6698 Ph: (832) 437-6531 | Noor Yazdanie, MD 26077 Nelson Way Ste 1201, Katy, TX 77494-6698 Ph: (832) 437-6531 |
News Archive
Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
NovaBay(R) Pharmaceuticals, Inc., a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, will deliver two poster presentations at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Substance abuse treatments that target main issues such as serious drug and alcohol addiction are not frequently being used to also wean adolescents from tobacco, a University of Georgia study finds.
› Verified 9 days ago
Yumna Ghouri, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 23900 Katy Fwy, Katy, TX 77494 Phone: 281-644-8111 Fax: 281-644-8144 | |
Dr. Shazia F Sheikh, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 23211 Red River Dr, Katy, TX 77494 Phone: 832-437-2427 Fax: 281-396-4798 | |
Dr. Gurjyot Kaur Doshi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1331 W Grand Pkwy N, Suite 340, Katy, TX 77493 Phone: 281-392-2757 Fax: 281-392-8148 | |
Alvin Raymond Co Tan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2510 W Grand Pkwy N, Katy, TX 77449 Phone: 713-442-4222 | |
William Alexander Currie, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 21700 Kingsland Blvd, Suite 201, Katy, TX 77450 Phone: 281-398-7954 Fax: 281-398-6320 | |
Ebba M Tsinopoulos, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 21720 Kingsland Blvd, Katy, TX 77450 Phone: 212-409-6121 Fax: 405-745-9602 | |
Jennifer Leigh Thomas, NP Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20710 Westheimer Pkwy, Katy, TX 77450 Phone: 936-277-1000 Fax: 936-994-9020 |